RODOS BIOTARGET
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells. RBT currently applies its TargoSphere® technology successfully in various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT’s TargoSphere® technology.
RODOS BIOTARGET
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Hanover, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.biotargeting.eu
Total Employee:
1+
Status:
Active
Contact:
49 173 317 0879
Total Funding:
3.6 M USD
Technology used in webpage:
SPF
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Michael Scolaro Co Founder & Chief Medical Consultant @ Rodos BioTarget
Co Founder & Chief Medical Consultant
Robert Gieseler Co Founder & CSO @ Rodos BioTarget
Co Founder & CSO
Jorg Ruppert Co Founder & Chief Consultant Investor Relations @ Rodos BioTarget
Co Founder & Chief Consultant Investor Relations
Founder
Investors List
Aescuvest
Aescuvest investment in Equity Crowdfunding - Rodos BioTarget
Christopher Isak
Christopher Isak investment in Seed Round - Rodos BioTarget
ERP Startfonds
ERP Startfonds investment in Venture Round - Rodos BioTarget
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Venture Round - Rodos BioTarget
Enjoyventure Management
Enjoyventure Management investment in Venture Round - Rodos BioTarget
Business Angels Agentur Ruhr
Business Angels Agentur Ruhr investment in Venture Round - Rodos BioTarget
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - Rodos BioTarget
Official Site Inspections
http://www.biotargeting.eu
- Host name: 185.53.177.31
- IP address: 185.53.177.31
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
Cannot get whois informations of this domain!!!
More informations about "Rodos BioTarget"
Rodos BioTarget - Crunchbase Company Profile & Funding
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active …See details»
Rodos BioTarget - VentureRadar
Website: http://www.biotargeting.eu/ Develops innovative treatments for infectious, autoimmune diseases, and cancers through targeted approaches focusing on immune cell-specific …See details»
Rodos BioTarget - Products, Competitors, Financials, Employees ...
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT's TargoSphere technology enables carrying a broad range of active agents …See details»
Rodos BioTarget GmbH Company Profile - Dun & Bradstreet
Overview. Company Description: ? Key Principal: Thomas Borcholte See more contacts. Industry: Scientific Research and Development Services , Professional, Scientific, and Technical …See details»
Rodos BioTarget erhält Startfinanzierung vom High-Tech …
Mai 2009. Die Rodos BioTarget GmbH (RBT) schließt erfolgreich eine Start-up-Finanzierungsrunde mit dem High-Tech Gründerfonds und dem hannover innovations fonds …See details»
Rodos BioTarget Company Profile 2024: Valuation, Funding
Description. Developer of nanomedicine and nanoparticles designed to achieve enhanced prophylactic and therapeutic approaches against unmet medical needs.See details»
Rodos BioTarget GmbH Rodos BioTaget GmbH: Fresh Capital for ...
Rodos Biotarget GmbH implemented financing measures over EUR 2.3 million. All of the company’s current investors have participated in the accompanying capital increase. The …See details»
Rodos Biotarget GmbH | LinkedIn
Rodos Biotarget GmbH | 86 followers on LinkedIn. Your partner with longstanding expertise in nanomedicine development and nanoparticle formulations. | Rodos BioTarget GmbH is a …See details»
Rodos BioTarget GmbH Asset Profile - Preqin
Biotechnology. About. Founded in 2008 and based in Hannover, Germany, Rodos BioTarget GmbH operates as a biopharmaceutical company that develops patented drug delivery …See details»
Rodos BioTarget (Rodos BioTarget GmbH) - Startbase
Entwicklung neuartiger Therapien für Infektions-, Autoimmun- und onkologische Krankheiten mit immunzell-spezifischem Targeting.See details»
Rodos Biotarget Company Profile - Office Locations, Competitors …
Overview. Rodos Biotarget is a biopharmaceutical company that develops pharmaceutical formulations for the active ingredients of its customers and partners from research institutions …See details»
Rodos BioTarget - Overview, News & Similar companies - ZoomInfo
View Rodos BioTarget (www.biotargeting.eu) location in Lower Saxony, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Rodos BioTarget Receives Growth Financing of EUR 2.6 m
RBT has invented and patented a unique platform technology targeted to the immune system that offers hope for effective remedies in various diseases.See details»
Secretary of Commerce Pays Visit to Rodos Biotarget - LinkedIn
Aug 27, 2015 · Commercialization of our proprietary technology platform is advanced with two in-house therapeutic applications: 1) TARGOBIOTICS® for the intracellular treatment of bacterial …See details»
Crowdfunding ebnet den Weg zu einer Kapitalerhöhung bei …
Medizinunternehmer und Business Angel Otto H. Gies investiert nach seinem initialen Crowdinvestment über eine direkte Beteiligung in das biopharmazeutische Unternehmen. …See details»
Fucosylated lipid nanocarriers loaded with antibiotics efficiently ...
Jun 10, 2021 · Abstract. Antibiotic treatment of tuberculosis (TB) is complex, lengthy, and can be associated with various adverse effects. As a result, patient compliance often is poor, thus …See details»
Home | Biotargeting - Πανεπιστήμιο Πατρών
Oct 20, 2010 · The Biomedical and Biotechnological Applications Research Network of University of Patras covers a broad spectrum of continuously evolving research in biomedicine and …See details»
Biotargeted nanomedicines for cancer: six tenets before you begin
The Biotargeting Working Group, consisting of more than 50 pharmaceutical scientists, engineers, biologists and clinicians, has been formed as part of the National Cancer Institute’s Alliance for …See details»
Caris Life Sciences Presents Data Demonstrating the Ability of …
Jun 21, 2018 · Caris’ ADAPT Biotargeting System employs poly-ligand profiling to survey a vast array of potential biomarkers and create a molecular profile that can identify patients most …See details»
Study Shows That Caris Life Sciences’ ADAPT Biotargeting …
Feb 12, 2020 · The results show that the ADAPT Biotargeting System has the resolution and sensitivity to discover differences in protein complexes using exosomes secreted by cancer …See details»